Income Tax Expense (Benefit) of Armata Pharmaceuticals, Inc. from 31 Dec 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Armata Pharmaceuticals, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2015 to 30 Sep 2025.
  • Armata Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $0.
  • Armata Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2018 was $328,000, a 75% increase from 2017.
  • Armata Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2017 was $1,302,000, a 134% decline from 2016.
  • Armata Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2016 was $556,000, a 662% decline from 2015.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Armata Pharmaceuticals, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 $0 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q1 2025 $0 $0 01 Jan 2025 31 Mar 2025 10-Q 12 Aug 2025 2025 Q2
Q3 2024 $0 $0 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $0 $0 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $0 $0 01 Jan 2024 31 Mar 2024 10-Q 12 Aug 2025 2025 Q2
Q3 2023 $0 $0 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $0 $0 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $0 $0 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q3 2022 $0 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $0 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $0 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q2 2017 $1,302,000 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q4 2015 $73,000 01 Oct 2015 31 Dec 2015 10-K 27 Mar 2017 2016 FY

Armata Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2018 $328,000 +$974,000 +75% 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2019 2018 FY
2017 $1,302,000 -$746,000 -134% 01 Jan 2017 31 Dec 2017 10-K 25 Mar 2019 2018 FY
2016 $556,000 -$483,000 -662% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2018 2017 FY
2015 $73,000 01 Jan 2015 31 Dec 2015 10-K 27 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.